Medical Care
Global Rubella Diagnostic Testing Market Research Report 2024
- Jan 26, 24
- ID: 25398
- Pages: 84
- Figures: 173
- Views: 28
Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects.
The global Rubella Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rubella Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Diagnostic Testing.
Report Scope
The Rubella Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rubella Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health
Segment by Type
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation
Segment by Application
Hospitals
Commercial
Physician Offices
Public Health Labs
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rubella Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Rubella Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Rubella Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rubella Diagnostic Testing.
Report Scope
The Rubella Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rubella Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rubella Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health
Segment by Type
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation
Segment by Application
Hospitals
Commercial
Physician Offices
Public Health Labs
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rubella Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Flow Cytometry
1.2.3 Latex Slide Agglutination Test
1.2.4 Monoclonal Antibodies
1.2.5 Immunoassays
1.2.6 Serological Testing
1.2.7 Clinical Evaluation
1.3 Market by Application
1.3.1 Global Rubella Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Commercial
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Diagnostic Testing Market Perspective (2019-2030)
2.2 Rubella Diagnostic Testing Growth Trends by Region
2.2.1 Global Rubella Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rubella Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Rubella Diagnostic Testing Market Dynamics
2.3.1 Rubella Diagnostic Testing Industry Trends
2.3.2 Rubella Diagnostic Testing Market Drivers
2.3.3 Rubella Diagnostic Testing Market Challenges
2.3.4 Rubella Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Diagnostic Testing Players by Revenue
3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rubella Diagnostic Testing Revenue
3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2023
3.5 Rubella Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Rubella Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Rubella Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Diagnostic Testing Breakdown Data by Type
4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Rubella Diagnostic Testing Breakdown Data by Application
5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rubella Diagnostic Testing Market Size (2019-2030)
6.2 North America Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rubella Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Rubella Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Diagnostic Testing Market Size (2019-2030)
7.2 Europe Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rubella Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Rubella Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Rubella Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rubella Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Rubella Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Bio Rad Laboratories
11.3.1 Bio Rad Laboratories Company Detail
11.3.2 Bio Rad Laboratories Business Overview
11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.3.5 Bio Rad Laboratories Recent Development
11.4 Biogate Laboratories
11.4.1 Biogate Laboratories Company Detail
11.4.2 Biogate Laboratories Business Overview
11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.4.5 Biogate Laboratories Recent Development
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Detail
11.5.2 BioMerieux SA Business Overview
11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.5.5 BioMerieux SA Recent Development
11.6 Cigna
11.6.1 Cigna Company Detail
11.6.2 Cigna Business Overview
11.6.3 Cigna Rubella Diagnostic Testing Introduction
11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.6.5 Cigna Recent Development
11.7 Diagnostic Laboratory of Oklahoma
11.7.1 Diagnostic Laboratory of Oklahoma Company Detail
11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.7.5 Diagnostic Laboratory of Oklahoma Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 HealthLink BC
11.9.1 HealthLink BC Company Detail
11.9.2 HealthLink BC Business Overview
11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.9.5 HealthLink BC Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Detail
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.10.5 Mayo Clinic Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 True Health
11.12.1 True Health Company Detail
11.12.2 True Health Business Overview
11.12.3 True Health Rubella Diagnostic Testing Introduction
11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.12.5 True Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Flow Cytometry
1.2.3 Latex Slide Agglutination Test
1.2.4 Monoclonal Antibodies
1.2.5 Immunoassays
1.2.6 Serological Testing
1.2.7 Clinical Evaluation
1.3 Market by Application
1.3.1 Global Rubella Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Commercial
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rubella Diagnostic Testing Market Perspective (2019-2030)
2.2 Rubella Diagnostic Testing Growth Trends by Region
2.2.1 Global Rubella Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rubella Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Rubella Diagnostic Testing Market Dynamics
2.3.1 Rubella Diagnostic Testing Industry Trends
2.3.2 Rubella Diagnostic Testing Market Drivers
2.3.3 Rubella Diagnostic Testing Market Challenges
2.3.4 Rubella Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rubella Diagnostic Testing Players by Revenue
3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rubella Diagnostic Testing Revenue
3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2023
3.5 Rubella Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Rubella Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Rubella Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rubella Diagnostic Testing Breakdown Data by Type
4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Rubella Diagnostic Testing Breakdown Data by Application
5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rubella Diagnostic Testing Market Size (2019-2030)
6.2 North America Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rubella Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Rubella Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rubella Diagnostic Testing Market Size (2019-2030)
7.2 Europe Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rubella Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Rubella Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rubella Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Rubella Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rubella Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rubella Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Rubella Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rubella Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Rubella Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Bio Rad Laboratories
11.3.1 Bio Rad Laboratories Company Detail
11.3.2 Bio Rad Laboratories Business Overview
11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.3.5 Bio Rad Laboratories Recent Development
11.4 Biogate Laboratories
11.4.1 Biogate Laboratories Company Detail
11.4.2 Biogate Laboratories Business Overview
11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.4.5 Biogate Laboratories Recent Development
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Detail
11.5.2 BioMerieux SA Business Overview
11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.5.5 BioMerieux SA Recent Development
11.6 Cigna
11.6.1 Cigna Company Detail
11.6.2 Cigna Business Overview
11.6.3 Cigna Rubella Diagnostic Testing Introduction
11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.6.5 Cigna Recent Development
11.7 Diagnostic Laboratory of Oklahoma
11.7.1 Diagnostic Laboratory of Oklahoma Company Detail
11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.7.5 Diagnostic Laboratory of Oklahoma Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 HealthLink BC
11.9.1 HealthLink BC Company Detail
11.9.2 HealthLink BC Business Overview
11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.9.5 HealthLink BC Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Detail
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.10.5 Mayo Clinic Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 True Health
11.12.1 True Health Company Detail
11.12.2 True Health Business Overview
11.12.3 True Health Rubella Diagnostic Testing Introduction
11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2019-2024)
11.12.5 True Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Latex Slide Agglutination Test
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Immunoassays
Table 6. Key Players of Serological Testing
Table 7. Key Players of Clinical Evaluation
Table 8. Global Rubella Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Rubella Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Rubella Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Rubella Diagnostic Testing Market Share by Region (2019-2024)
Table 12. Global Rubella Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Rubella Diagnostic Testing Market Share by Region (2025-2030)
Table 14. Rubella Diagnostic Testing Market Trends
Table 15. Rubella Diagnostic Testing Market Drivers
Table 16. Rubella Diagnostic Testing Market Challenges
Table 17. Rubella Diagnostic Testing Market Restraints
Table 18. Global Rubella Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Rubella Diagnostic Testing Market Share by Players (2019-2024)
Table 20. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2023)
Table 21. Ranking of Global Top Rubella Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Rubella Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rubella Diagnostic Testing Product Solution and Service
Table 25. Date of Enter into Rubella Diagnostic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rubella Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Rubella Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Rubella Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Rubella Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Rubella Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Rubella Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Rubella Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Rubella Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Rubella Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Abbott Laboratories Company Detail
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Rubella Diagnostic Testing Product
Table 53. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. Beckman Coulter Company Detail
Table 56. Beckman Coulter Business Overview
Table 57. Beckman Coulter Rubella Diagnostic Testing Product
Table 58. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 59. Beckman Coulter Recent Development
Table 60. Bio Rad Laboratories Company Detail
Table 61. Bio Rad Laboratories Business Overview
Table 62. Bio Rad Laboratories Rubella Diagnostic Testing Product
Table 63. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 64. Bio Rad Laboratories Recent Development
Table 65. Biogate Laboratories Company Detail
Table 66. Biogate Laboratories Business Overview
Table 67. Biogate Laboratories Rubella Diagnostic Testing Product
Table 68. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 69. Biogate Laboratories Recent Development
Table 70. BioMerieux SA Company Detail
Table 71. BioMerieux SA Business Overview
Table 72. BioMerieux SA Rubella Diagnostic Testing Product
Table 73. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 74. BioMerieux SA Recent Development
Table 75. Cigna Company Detail
Table 76. Cigna Business Overview
Table 77. Cigna Rubella Diagnostic Testing Product
Table 78. Cigna Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 79. Cigna Recent Development
Table 80. Diagnostic Laboratory of Oklahoma Company Detail
Table 81. Diagnostic Laboratory of Oklahoma Business Overview
Table 82. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product
Table 83. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 84. Diagnostic Laboratory of Oklahoma Recent Development
Table 85. GlaxoSmithKline Company Detail
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Rubella Diagnostic Testing Product
Table 88. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. HealthLink BC Company Detail
Table 91. HealthLink BC Business Overview
Table 92. HealthLink BC Rubella Diagnostic Testing Product
Table 93. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 94. HealthLink BC Recent Development
Table 95. Mayo Clinic Company Detail
Table 96. Mayo Clinic Business Overview
Table 97. Mayo Clinic Rubella Diagnostic Testing Product
Table 98. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 99. Mayo Clinic Recent Development
Table 100. Ortho Clinical Diagnostics Company Detail
Table 101. Ortho Clinical Diagnostics Business Overview
Table 102. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product
Table 103. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 104. Ortho Clinical Diagnostics Recent Development
Table 105. True Health Company Detail
Table 106. True Health Business Overview
Table 107. True Health Rubella Diagnostic Testing Product
Table 108. True Health Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 109. True Health Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rubella Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rubella Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Flow Cytometry Features
Figure 4. Latex Slide Agglutination Test Features
Figure 5. Monoclonal Antibodies Features
Figure 6. Immunoassays Features
Figure 7. Serological Testing Features
Figure 8. Clinical Evaluation Features
Figure 9. Global Rubella Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Rubella Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 11. Hospitals Case Studies
Figure 12. Commercial Case Studies
Figure 13. Physician Offices Case Studies
Figure 14. Public Health Labs Case Studies
Figure 15. Other Case Studies
Figure 16. Rubella Diagnostic Testing Report Years Considered
Figure 17. Global Rubella Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Rubella Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Rubella Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 20. Global Rubella Diagnostic Testing Market Share by Players in 2023
Figure 21. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2023
Figure 23. North America Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 25. United States Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 29. Germany Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Rubella Diagnostic Testing Market Share by Region (2019-2030)
Figure 37. China Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 45. Mexico Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 49. Turkey Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 52. Beckman Coulter Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 53. Bio Rad Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 54. Biogate Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 55. BioMerieux SA Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 56. Cigna Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 57. Diagnostic Laboratory of Oklahoma Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 59. HealthLink BC Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 60. Mayo Clinic Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 61. Ortho Clinical Diagnostics Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 62. True Health Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Flow Cytometry
Table 3. Key Players of Latex Slide Agglutination Test
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Immunoassays
Table 6. Key Players of Serological Testing
Table 7. Key Players of Clinical Evaluation
Table 8. Global Rubella Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Rubella Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Rubella Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Rubella Diagnostic Testing Market Share by Region (2019-2024)
Table 12. Global Rubella Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Rubella Diagnostic Testing Market Share by Region (2025-2030)
Table 14. Rubella Diagnostic Testing Market Trends
Table 15. Rubella Diagnostic Testing Market Drivers
Table 16. Rubella Diagnostic Testing Market Challenges
Table 17. Rubella Diagnostic Testing Market Restraints
Table 18. Global Rubella Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Rubella Diagnostic Testing Market Share by Players (2019-2024)
Table 20. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2023)
Table 21. Ranking of Global Top Rubella Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Rubella Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Rubella Diagnostic Testing Product Solution and Service
Table 25. Date of Enter into Rubella Diagnostic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rubella Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Rubella Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Rubella Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Rubella Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Rubella Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Rubella Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Rubella Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Rubella Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Rubella Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Rubella Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Abbott Laboratories Company Detail
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories Rubella Diagnostic Testing Product
Table 53. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. Beckman Coulter Company Detail
Table 56. Beckman Coulter Business Overview
Table 57. Beckman Coulter Rubella Diagnostic Testing Product
Table 58. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 59. Beckman Coulter Recent Development
Table 60. Bio Rad Laboratories Company Detail
Table 61. Bio Rad Laboratories Business Overview
Table 62. Bio Rad Laboratories Rubella Diagnostic Testing Product
Table 63. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 64. Bio Rad Laboratories Recent Development
Table 65. Biogate Laboratories Company Detail
Table 66. Biogate Laboratories Business Overview
Table 67. Biogate Laboratories Rubella Diagnostic Testing Product
Table 68. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 69. Biogate Laboratories Recent Development
Table 70. BioMerieux SA Company Detail
Table 71. BioMerieux SA Business Overview
Table 72. BioMerieux SA Rubella Diagnostic Testing Product
Table 73. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 74. BioMerieux SA Recent Development
Table 75. Cigna Company Detail
Table 76. Cigna Business Overview
Table 77. Cigna Rubella Diagnostic Testing Product
Table 78. Cigna Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 79. Cigna Recent Development
Table 80. Diagnostic Laboratory of Oklahoma Company Detail
Table 81. Diagnostic Laboratory of Oklahoma Business Overview
Table 82. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product
Table 83. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 84. Diagnostic Laboratory of Oklahoma Recent Development
Table 85. GlaxoSmithKline Company Detail
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Rubella Diagnostic Testing Product
Table 88. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. HealthLink BC Company Detail
Table 91. HealthLink BC Business Overview
Table 92. HealthLink BC Rubella Diagnostic Testing Product
Table 93. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 94. HealthLink BC Recent Development
Table 95. Mayo Clinic Company Detail
Table 96. Mayo Clinic Business Overview
Table 97. Mayo Clinic Rubella Diagnostic Testing Product
Table 98. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 99. Mayo Clinic Recent Development
Table 100. Ortho Clinical Diagnostics Company Detail
Table 101. Ortho Clinical Diagnostics Business Overview
Table 102. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product
Table 103. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 104. Ortho Clinical Diagnostics Recent Development
Table 105. True Health Company Detail
Table 106. True Health Business Overview
Table 107. True Health Rubella Diagnostic Testing Product
Table 108. True Health Revenue in Rubella Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 109. True Health Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rubella Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rubella Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Flow Cytometry Features
Figure 4. Latex Slide Agglutination Test Features
Figure 5. Monoclonal Antibodies Features
Figure 6. Immunoassays Features
Figure 7. Serological Testing Features
Figure 8. Clinical Evaluation Features
Figure 9. Global Rubella Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Rubella Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 11. Hospitals Case Studies
Figure 12. Commercial Case Studies
Figure 13. Physician Offices Case Studies
Figure 14. Public Health Labs Case Studies
Figure 15. Other Case Studies
Figure 16. Rubella Diagnostic Testing Report Years Considered
Figure 17. Global Rubella Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Rubella Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Rubella Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 20. Global Rubella Diagnostic Testing Market Share by Players in 2023
Figure 21. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2023
Figure 23. North America Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 25. United States Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 29. Germany Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Rubella Diagnostic Testing Market Share by Region (2019-2030)
Figure 37. China Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 45. Mexico Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Rubella Diagnostic Testing Market Share by Country (2019-2030)
Figure 49. Turkey Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Rubella Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 52. Beckman Coulter Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 53. Bio Rad Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 54. Biogate Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 55. BioMerieux SA Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 56. Cigna Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 57. Diagnostic Laboratory of Oklahoma Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 59. HealthLink BC Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 60. Mayo Clinic Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 61. Ortho Clinical Diagnostics Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 62. True Health Revenue Growth Rate in Rubella Diagnostic Testing Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232